There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as particularly promising.
Workin' 9 to 5 doesn't *just* have to be a way to make a living; it can be a little fun, too. View Entire Post › ...
David Gardner is The Motley Fool's co-founder and chief rule breaker. In this Motley Fool Money episode, Motley Fool host ...
State and local leaders in California continue to get questions about their fire preparedness and the adequacy of ...
High-Protein Breakfast Ideas That Will Help You Lose Weight Without alcohol, they’re less fattening, right? Yes and no. It’s true that alcohol adds calories, but so do the ingredients you’re swapping ...